I don't know what technical expertise Bioepis has, not sure if it has anything to do with Remicade is chimeric mAb, Enbrel is fusion protein, while Humira is fully human mAb. Most companies are relatively secretive about why they chose to develop one over the others for biosimilar.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.